CA Stock MarketDetailed Quotes
GUD Knight Therapeutics Inc
- 5.340
- +0.090+1.71%
15min DelayMarket Closed Dec 27 16:00 ET
538.29MMarket Cap-18.41P/E (TTM)
5.360High5.250Low92.13KVolume5.250Open5.250Pre Close490.15KTurnover6.23052wk High0.14%Turnover Ratio100.80MShares5.08552wk Low-0.29EPS TTM348.25MFloat Cap11.030Historical HighLossP/E (Static)65.22MShs Float3.510Historical Low-0.16EPS LYR2.10%Amplitude--Dividend TTM0.70P/B1Lot Size--Div YieldTTM
Knight Therapeutics Inc Key Stats
EPS
According to the latest financial report of Knight Therapeutics Inc, the latest earnings per share (TTM) for the company is 0.00. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CAD
Quarterly
Loading...
FCF
Interested in knowing about Knight Therapeutics Inc's free cash flow? The latest report shows it as 2.97M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: CAD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Knight Therapeutics Inc shows that the company's current ratio is 3.36, indicating healthy liquidity.
Currency: CAD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Knight Therapeutics Inc, the quick ratio is 2.33, indicating that the company can meet its short-term debt obligations.
Currency: CAD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Knight Therapeutics Inc? The latest ROE figure is 0.01%, indicating that the company has stable profitability.
Currency: CAD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Knight Therapeutics Inc, the total asset return on investment (ROA) is 0.01%.
Currency: CAD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Knight Therapeutics Inc's latest financial report to see how their gross margin is doing - currently at 48.79%.
Currency: CAD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Knight Therapeutics Inc, the net profit margin is 0.09%, which is a good sign for its profitability.
Currency: CAD
Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Price
% Chg
No Data